Case Reports
Erythropoietn; A rare culprit of anemia in chronic kidney disease
Authors:
Piratheepan Navaradnam ,
teaching hospital jaffna, LK
Thaneshwary Sooriyakumar
teaching hospital jaffna, LK
Abstract
Erythropoietin-induced antibody-mediated pure red cell aplasia is a rare and unexpected devastating adverse effect of erythropoietin analog. Patient and product-related factors, along with factors related to storage, determine the immunogenicity of erythropoietin. Early identification and withdrawal of erythropoietin with immunosuppressive therapy would improve the outcome. Here we present a 69-year-old male with chronic kidney disease treated with erythropoietin, had refractory anemia due to antibody-mediated pure redcell aplasia.
How to Cite:
Navaradnam, P., Kumanan, T. and Sooriyakumar, T., 2021. Erythropoietn; A rare culprit of anemia in chronic kidney disease. Journal of the Postgraduate Institute of Medicine, 8(1), pp.E141 1–5. DOI: http://doi.org/10.4038/jpgim.8319
Published on
30 Jun 2021.
Peer Reviewed
Downloads
